semaglutide cardiovascular outcomes news 2025 and by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial Cardiovascular Outcomes Associated with Semaglutide

Weight loss drugs like Wegovy may lower the odds of developing an infection of the newly implanted joint in people undergoing hip replacement, new research finds.

Safety info: GLP-1 medications are used to treat obesity or overweight (with weight-related problems), along with diet and exercise

Learn how GLP-1 drugs like Ozempic can affect your teeth and gums, from dry mouth to gum disease risks

Discover effective strategies for weight loss and combat the global obesity epidemic

Find out if your or your loved one's insurance covers Wegovy (semaglutide) injection 2.4 mg and the estimated cost at the pharmacy.

Results Mean baseline age was 47 years, 63% were female, BMI was 40 kg/m2, and HbA1c was 5.86%